// App-Quantinova.ai

579 : Rosuvastatin Lowers Circulating Tissue Factor Antigen-Bearing Microparticles In Metastatic Breast Cancer: A Phase II, Multi-Dose, Randomized Trial (MicroSTAT Trial)

Researchers

Presenter

  • Jeffrey I. Zwicker

Principal Investigators

  • Erica L. Mayer

  • Federico Campigotto

  • Julia Geddings

  • Herold Christina

  • Sheryl Bowley

  • Gerburg Wulf

  • Gary Horowitz

  • Donna S. Neuberg

  • Nigel Mackman

  • Bruce Furie

Medical Centers

  • Beth Israel Deaconess Medical Center, Boston, MA

  • UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC

  • Medicine - Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • C reactive protein

  • Coagulation Factor III, Tissue Factor

  • D-dimer

Drug/Treatment

  • Rosuvastatin

  • Heparin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved